Entering text into the input field will update the search result below

SI-BONE, Inc. (SIBN) CEO Laura Francis on Q1 2021 Results - Earnings Call Transcript

May 03, 2021 8:26 PM ETSI-BONE, Inc. (SIBN)
SA Transcripts profile picture
SA Transcripts

SI-BONE, Inc. (NASDAQ:SIBN) Q1 2021 Earnings Conference Call May 3, 2021 4:30 PM ET

Company Participants

Matt Basco - Gilmartin Group

Laura Francis - Chief Executive Officer

Anshul Maheshwari - Chief Financial Officer

Conference Call Participants

Bob Hopkins - Bank of America

Kaila Krum - Truist Securities

Drew Ranieri - Morgan Stanley

Dave Turkaly - JMP Securities

Brendon Folkes - Cantor Fitzgerald

David Saxon - Needham

Kyle Rose - Canaccord


Good afternoon, and welcome to SI-BONE's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a questions and answer session towards the end of today’s call.

As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Matt Basco from the Gilmartin Group for a few introductory comments.

Matt Basco

Thank you for participating in today's call. Joining me are Laura Francis, Chief Executive Officer; and Anshul Maheshwari, Chief Financial Officer. Earlier today, SI-BONE released financial results for the quarter ended March 31, 2021. And a copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements.

These forward-looking statements are based on the company's current expectations and inherently involve risks and uncertainties. These risks include the impact that COVID-19 pandemic will have on the ability and desire of patients and physicians to undergo procedures using the iFuse Implant System, the duration of the COVID-19

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About SIBN

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on SIBN

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.